Pancreatitis Severity and Gut Bacteria Study
Part of Digestive system clinical trials.
This study looks at how the bacteria in your gut (microbiome) might affect the severity of a first-time acute pancreatitis attack. It aims to see if certain gut bacteria can predict how serious the illness will be, which could help doctors treat patients better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with acute pancreatitis for the first time in the last 2 days.
- You are 18 years old or older.
- You can understand and sign a consent form.
- You have not had more than 2 attacks of pancreatitis before.
- You do not have signs of long-term (chronic) pancreatitis.
- You are not being transferred from another hospital after being there for more than 2 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a specific friendly bacterium (Bifidobacterium longum) can help people with moderate-to-severe acute pancreatitis recover faster. Participants will either receive the bacterium or a placebo (inactive pill) for the first few days of treatment.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.
This study observes adults with acute pancreatitis to learn more about how the condition presents and what happens to patients over time. By participating, you can help researchers improve care for this painful condition.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.